Accéder au contenu
MilliporeSigma

Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model.

Alzheimer's & dementia (New York, N. Y.) (2018-10-20)
Mythily Srinivasan, Niloy Lahiri, Anish Thyagarajan, Emily Witek, Debra Hickman, Debomoy K Lahiri
RÉSUMÉ

Glucocorticoid-induced leucine zipper is a regulatory protein that sequesters activated nuclear factor-kappa B p65. Previously, we showed that rationally designed analogs of the p65-binding domain of glucocorticoid-induced leucine zipper, referred to as glucocorticoid-induced leucine zipper analogs (GAs), inhibited amyloid β-induced metabolic activity and inflammatory cytokines in mixed brain cell cultures. Here, we investigate the therapeutic efficacy of GA in an Alzheimer's disease model. GA and control peptides were synthesized covalently as peptide amides with the cell-penetrating agent. C57Bl/6J mice induced with lipopolysaccharide-mediated neuroinflammation (250 mg/kg i.p/day for six days) were treated on alternate days with GA-1, GA-2, or control peptides (25 mg/kg i.v). Brain tissues were assessed for gliosis, cytokines, and antiapoptotic factors. The brain tissues of GA-1- and GA-2-treated mice exhibited significantly reduced gliosis, suppressed inflammatory cytokines, and elevated antiapoptotic factors. The antineuroinflammatory effects of GA suggest potential therapeutic application for Alzheimer's disease.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps anti-protéine acide fibrillaire gliale, clone GA5, clone GA5, Chemicon®, from mouse
Sigma-Aldrich
Anticorps anti-Iba1/AIF1, clone 20A12.1, from mouse
Sigma-Aldrich
Anti-NFκB Antibody, p65 subunit, active subunit, clone 12H11, clone 12H11, Chemicon®, from mouse
Sigma-Aldrich
Anti-CD11b Antibody (human/mouse), Biotin, clone M1/70, clone M1/70, 0.5 mg/mL, from rat